Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/28/1996 | WO1996009385A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
03/28/1996 | WO1996009384A1 Eph receptor ligands, and uses related thereto |
03/28/1996 | WO1996009383A1 Process for producing recombinant hepatocyte proliferating substance |
03/28/1996 | WO1996009382A1 gp130 LACKING THE TRANSMEMBRANE DOMAIN |
03/28/1996 | WO1996009381A1 Promoter for the receptor tyrosine kinase, tie |
03/28/1996 | WO1996009380A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
03/28/1996 | WO1996009379A1 Dna purification and isolation using a solid phase |
03/28/1996 | WO1996009378A1 Overexpression of mammalian and viral proteins |
03/28/1996 | WO1996009377A1 Transgenic animals expressing human coagulation factor viii and von willebrand factor |
03/28/1996 | WO1996009375A1 Dna encoding human papillomavirus type 6a |
03/28/1996 | WO1996009374A1 Human galactokinase gene |
03/28/1996 | WO1996009373A1 Fibroblasts for the treatment of muscular disorders |
03/28/1996 | WO1996009324A1 Ecdn protein and dna coding for the same |
03/28/1996 | WO1996009323A1 Il-1 receptor antagonists with enhanced inhibitory activity |
03/28/1996 | WO1996009320A1 Antigenic polypeptide of chlamydia pneumoniae |
03/28/1996 | WO1996009317A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
03/28/1996 | WO1996009316A1 Parallel selex |
03/28/1996 | WO1996009315A1 Dna photocleavage using texaphyrins |
03/28/1996 | WO1996009311A1 Human transcription factor iia |
03/28/1996 | WO1996009308A1 High efficiency method for isolating target substances using a multisample separation device |
03/28/1996 | WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
03/28/1996 | WO1996009066A2 Method of treatment of human immunodeficiency virus (hiv) infection |
03/28/1996 | WO1996007761A3 Method for testing for mutations in dna from a patient sample |
03/28/1996 | WO1996007749A3 Methods and compositions for inhibiting production of replication competent virus |
03/28/1996 | WO1996007738A3 Modified human c3 proteins |
03/28/1996 | WO1996006929A3 Rapid expansion method ('rem') for in vitro propagation of t lymphocytes |
03/28/1996 | WO1996005314A3 Protein toxins active against lepidopteran pests |
03/28/1996 | WO1996005295A3 An improved cleaning composition |
03/28/1996 | WO1996004392A3 Transgenic cereal plants |
03/28/1996 | WO1996003527A3 Diagnostic method and probe |
03/28/1996 | DE4441197C1 Schizosaccharomyces pombe expression plasmids |
03/28/1996 | DE4435366A1 DNA encoding plant citrate synthase |
03/28/1996 | DE4431432A1 Isolation of DNA from biological prepn(s). and amplification of highly degraded DNA |
03/28/1996 | CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
03/28/1996 | CA2200724A1 Human galactokinase gene |
03/28/1996 | CA2200709A1 In vitro models of cns function and dysfunction |
03/28/1996 | CA2200684A1 Antigen binding peptides (abtides) from peptide libraries |
03/28/1996 | CA2200611A1 Cancer treatment by expression of differentiation factor receptor |
03/28/1996 | CA2200583A1 Human galactokinase gene |
03/28/1996 | CA2200571A1 Dna photocleavage using texaphryns |
03/28/1996 | CA2200434A1 Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogensin crops |
03/28/1996 | CA2200357A1 Nucleic acid fragment and products derived therefrom |
03/28/1996 | CA2200354A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
03/28/1996 | CA2200329A1 Novel anti-vh3-15 reagents, vh3-15 polypeptides, cell surface antigens, and methods for their detection and use |
03/28/1996 | CA2200294A1 Enrichment of fetal cells from maternal blood |
03/28/1996 | CA2199748A1 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
03/28/1996 | CA2199727A1 Ribozyme treatment of diseases or conditions related to levels of plasma lipoprotein (a) ¬lp(a)| by inhibiting apolipoprotein (a) ¬apo(a)| |
03/28/1996 | CA2199470A1 Allelic variation of the serotonin 5ht2c receptor |
03/28/1996 | CA2198774A1 Topographic genotyping |
03/28/1996 | CA2198379A1 Fibroblasts for the treatment of muscular disorders |
03/27/1996 | EP0703295A1 Vaccine composition comprising recombinant BCG expressing gp 63 fusion protein |
03/27/1996 | EP0703242A1 Human-origin tumor cell proliferation inhibiting factor |
03/27/1996 | EP0702730A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
03/27/1996 | EP0702729A1 Chemical process for amplifying and detecting nucleic acid sequences |
03/27/1996 | EP0702728A1 Magnetic cycle reaction |
03/27/1996 | EP0702727A1 Dyes designed for high sensitivity detection of double-stranded dna |
03/27/1996 | EP0702726A1 Immunoassay reagents and methods for detecting brequinar and analogs |
03/27/1996 | EP0702725A1 Method for recombinant production of biologically active polypeptides |
03/27/1996 | EP0702724A1 Mengovirus as a vector for expression of foreign polypeptides |
03/27/1996 | EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
03/27/1996 | EP0702722A1 Plasmids suitable for gene therapy |
03/27/1996 | EP0702721A1 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
03/27/1996 | EP0702720A1 Method for defined deletions of dna |
03/27/1996 | EP0702718A1 An enzyme exhibiting mannanase activity |
03/27/1996 | EP0702717A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
03/27/1996 | EP0702716A1 Ribozyme gene therapy for hiv infection and aids |
03/27/1996 | EP0702715A1 CLONING AND EXPRESSION OF THE CHONDROITINASE I AND II GENES FROM $i(P. VULGARIS) |
03/27/1996 | EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1) |
03/27/1996 | EP0702694A1 $i(PSEUDOMONAS SYRINGAE) pv. $i(SYRINGAE hrpZ) GENE |
03/27/1996 | EP0702693A1 Tandem synthetic hiv-1 peptides |
03/27/1996 | EP0702692A1 Regulation of antigen presentation |
03/27/1996 | EP0702690A1 Freeze-dried compositions comprising rna |
03/27/1996 | EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
03/27/1996 | EP0702564A1 Novel attenuated pseudomonas aeruginosa strains |
03/27/1996 | EP0702554A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
03/27/1996 | EP0702518A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
03/27/1996 | EP0702516A1 Genetic immunization with cationic lipids |
03/27/1996 | EP0483224B1 Inducible expression vectors |
03/27/1996 | CN1119459A Process for preparing cancer vaccines |
03/27/1996 | CN1119458A Nucleic acid pharmaceuticals |
03/27/1996 | CN1119457A Bone stimulating factor |
03/27/1996 | CN1119442A Protein Rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
03/27/1996 | CN1119121A Crystalline interleukin-4 |
03/27/1996 | CN1031411C Method for producing propionyl spiramycin by assortment of genes |
03/27/1996 | CA2159044A1 Method of quantitating nucleic acids |
03/26/1996 | US5502273 Biosynthesis of polylactones, expression of genes from alcaligenes |
03/26/1996 | US5502177 Pyrimidine derivatives for labeled binding partners |
03/26/1996 | US5502176 Gene expression |
03/26/1996 | US5502167 CDR grafted humanised chimeric T-cell antibodies |
03/26/1996 | US5502166 Information transmission at a synapse, central nervous systems |
03/26/1996 | US5502034 Methods for producing thrombin |
03/26/1996 | US5501983 Assay of free and complexed prostate-specific antigen |
03/26/1996 | US5501979 Herpes simplex virus type I expression vector |
03/26/1996 | US5501975 Transformed host cell, dibasic processing endoprotease, improved yield of correctly folded proteins |
03/26/1996 | US5501970 Nucleotide sequences coding for ribosome inactivating proteins |
03/26/1996 | US5501969 Bone disorders, antitumor |
03/26/1996 | US5501967 Process for the site-directed integration of DNA into the genome of plants |
03/26/1996 | US5501964 Diagnositcs, forensics, genotyping |
03/26/1996 | US5501963 Amplification and detection of nucleic acids in blood samples |
03/26/1996 | US5501962 Culture of cells for polypeptides |